von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS-Reference-Cited by-同舟云学术

von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

Published:2023-04 Issue:4 Volume:21 Page:787-799
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Pagliari Maria Teresa,Budde Ulrich,Baronciani Luciano,Eshghi Peyman,Ahmadinejad Minoo,Badiee Zahra,Baghaipour Mohammad-Reza,Benítez Hidalgo Olga,Biguzzi Eugenia,Bodó Imre,Castaman Giancarlo,Goudemand Jenny,Karimi Mehran,Keikhaei Bijan,Lassila Riitta,Leebeek Frank W.G.,Lopez Fernandez Maria Fernanda,Marino Renato,Oldenburg Johannes,Peake Ian,Santoro Cristina,Schneppenheim Reinhard,Tiede Andreas,Toogeh Gholamreza,Tosetto Alberto,Trossaert Marc,Yadegari Hamideh,Zetterberg Eva M.K.,Mannucci Pier Mannuccio,Federici Augusto B.,Eikenboom Jeroen,Peyvandi Flora^ORCID

Funder

Ministero della Salute

Octapharma AG

Baxalta

Publisher

Elsevier BV

Subject

Hematology

Reference31 articles.

1. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor;Sadler;J Thromb Hemost,2006

2. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA);Nichols;Haemophilia,2008

3. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease;James;Blood Adv,2021